The United Kingdom national screening committee has asked the health technology assessment (HTA) programme to undertake two studies on prenatal screening for group B streptococcal disease. These studies are still in progress.
The first study is on prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost effectiveness and expected value of information analyses.
The second study is on prenatal screening for group B streptococcal disease: protocol development for a possible clinical trial.
Details of all ongoing reports and research outputs can be found on the HTA’s website at www.hta.nhsweb. nhs.uk.